(Q63320009)
Statements
A Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of IPX159 in the Treatment of Moderate to Severe Restless Legs Syndrome (RLS) (English)
0 references
November 2011
0 references
February 2013
0 references
159
0 references
18 year
0 references
70 year
0 references